David M. Chao - 01 Feb 2025 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Administrative Officer
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
01 Feb 2025
Net transactions value
-$225,442
Form type
4
Filing time
04 Feb 2025, 16:55:27 UTC
Previous filing
31 Dec 2024
Next filing
19 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Tax liability $225,442 -13,324 -5.5% $16.92 228,507 01 Feb 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.